Association of the Hepatic Steatosis Index and Fatty Liver Index With Breast Cancer Risk: A Nationwide Cohort Study

Background This study aimed to evaluate the association between the Hepatic Steatosis Index (HSI) and the Fatty Liver Index (FLI), both serving as surrogate indices of hepatic steatosis, and breast cancer risk among Korean women. Methods This nationwide cohort study included 3,629,375 women aged ≥40 years who participated in a national breast cancer screening program between 2009 and 2010. HSI and FLI were categorized as follows: HSI (<30, 30-35.9, ≥36) and FLI (<30, 30-59.9, ≥60). Combined HSI and FLI categories were also examined. Cox proportional hazards regression and restricted cubic spline models were used to estimate the associations. Results Postmenopausal women with HSI ≥36 and FLI ≥60 had significantly higher risks of breast cancer (hazard ratios [HRs] 1.48, 95% confidence intervals [CIs] 1.43-1.53; HR 1.41, 95% CI 1.35-1.47, respectively) than those in the lowest groups, whereas no significant associations were observed among women who were premenopausal at baseline. Combined HSI-FLI analyses showed the highest breast cancer risk among women classified as high-risk by both indices (HR 1.68, 95% CI 1.59-1.77). Conclusions Higher HSI and FLI were associated with an increased risk of breast cancer in postmenopausal women, demonstrating a dose-response relationship. These findings highlight the potential role of metabolic liver dysfunction in the development of postmenopausal breast cancer. Impact These findings support the role of metabolic liver dysfunction in postmenopausal breast carcinogenesis and suggest that simple, noninvasive fatty liver indices may help identify women who could benefit from targeted prevention strategies.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2026-11-20
DOI
https://doi.org/10.1158/1055-9965.epi-26-0879
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of the Hepatic Steatosis Index and Fatty Liver Index With Breast Cancer Risk: A Nationwide Cohort Study

Habyeong Kang, Thị Xuân Mai Trần, Boyoung Park, Mi Kyung Kim et al.
6 links
Cancer Epidemiology Biomarkers & Prevention
Liver Disease Diagnosis and Treatment
article

Association of the Hepatic Steatosis Index and Fatty Liver Index With Breast Cancer Risk: A Nationwide Cohort Study

Habyeong Kang, Thị Xuân Mai Trần, Boyoung Park, Mi Kyung Kim, So-Hyun Park, Seungmi Yoo
article en

Abstract

Background This study aimed to evaluate the association between the Hepatic Steatosis Index (HSI) and the Fatty Liver Index (FLI), both serving as surrogate indices of hepatic steatosis, and breast cancer risk among Korean women. Methods This nationwide cohort study included 3,629,375 women aged ≥40 years who participated in a national breast cancer screening program between 2009 and 2010. HSI and FLI were categorized as follows: HSI (<30, 30-35.9, ≥36) and FLI (<30, 30-59.9, ≥60). Combined HSI and FLI categories were also examined. Cox proportional hazards regression and restricted cubic spline models were used to estimate the associations. Results Postmenopausal women with HSI ≥36 and FLI ≥60 had significantly higher risks of breast cancer (hazard ratios [HRs] 1.48, 95% confidence intervals [CIs] 1.43-1.53; HR 1.41, 95% CI 1.35-1.47, respectively) than those in the lowest groups, whereas no significant associations were observed among women who were premenopausal at baseline. Combined HSI-FLI analyses showed the highest breast cancer risk among women classified as high-risk by both indices (HR 1.68, 95% CI 1.59-1.77). Conclusions Higher HSI and FLI were associated with an increased risk of breast cancer in postmenopausal women, demonstrating a dose-response relationship. These findings highlight the potential role of metabolic liver dysfunction in the development of postmenopausal breast cancer. Impact These findings support the role of metabolic liver dysfunction in postmenopausal breast carcinogenesis and suggest that simple, noninvasive fatty liver indices may help identify women who could benefit from targeted prevention strategies.

Cancer Epidemiology Biomarkers & Prevention
Hanyang University (KR)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon